This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nehgme, R. Articles by Carpenter, T. O. Search for Related Content PubMed PubMed Citation Articles by Nehgme, R. Articles by Carpenter, T. O.

Cardiovascular Abnormalities in Patients with X-Linked Hypophosphatemia

Department of Pediatrics, Sections of Pediatric Cardiology (R.N., J.T.F.) and Endocrinology (C.S., T.O.C.), Yale University School of Medicine, New Haven, Connecticut 06520

Address all correspondence and requests for reprints to: Rodrigo Nehgme, M.D., Department of Pediatrics (Cardiology), Yale University School of Medicine, Room 302 LLCI, 333 Cedar Street, New Haven, Connecticut 06520.

Treatment for X-linked hypophosphatemia (XLH; vitamin D metabolites and phosphate salts) may result in hypercalcemia, hypercalciuria, nephrocalcinosis, and hyperparathyroidism. Cardiovascular abnormalities occur in association with these complications, but have not been reported in XLH. We hypothesized that such abnormalities may occur in XLH and evaluated cardiovascular status in 13 patients with this disease.

All patients were asymptomatic and had normal cardiovascular physical examinations and Holter studies. Serum calcium and creatinine clearance were normal in all. However, all patients had mild to moderate nephrocalcinosis. Left ventricular hypertrophy was diagnosed by electrocardiogram in three and by ultrasonography in seven children. Baseline blood pressure (BP) was normal (mean ± SD, 116 ± 15/74 ± 6 mm Hg). During exercise stress testing, systolic BP increased in all patients, but the maximal systolic pressure was less than that in healthy age- and sex-matched controls (156 ± 20 vs. 175 ± 23; P = 0.002, by t test). An abnormal increase in diastolic BP occurred at all levels of work load in XLH patients; their peak exercise diastolic BP was 91 ± 12 vs. 72 ± 6 mm Hg in controls (P < 0.0001, by t test).

Whether these abnormal findings are primary defects in XLH or represent complications of treatment is unclear. Patients with XLH should be monitored closely for the development of hypertension and left ventricular hypertrophy. Investigation of the mechanisms involved and establishment of therapeutic guidelines are indicated.

This article has been cited by other articles:

				H. Raeder, N. Shaw, C. Netelenbos, and R. Bjerknes A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S101 - S105. [Abstract] [Full Text] [PDF]